"Cancer Vaccines" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Vaccines or candidate vaccines designed to prevent or treat cancer. Vaccines are produced using the patient's own whole tumor cells as the source of antigens, or using tumor-specific antigens, often recombinantly produced.
Descriptor ID |
D019496
|
MeSH Number(s) |
D20.215.894.200
|
Concept/Terms |
Cancer Vaccines- Cancer Vaccines
- Vaccines, Tumor
- Vaccines, Neoplasm
- Tumor Vaccines
- Vaccines, Cancer
- Neoplasm Vaccines
|
Below are MeSH descriptors whose meaning is more general than "Cancer Vaccines".
Below are MeSH descriptors whose meaning is more specific than "Cancer Vaccines".
This graph shows the total number of publications written about "Cancer Vaccines" by people in this website by year, and whether "Cancer Vaccines" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1996 | 0 | 1 | 1 |
1997 | 4 | 1 | 5 |
1998 | 5 | 2 | 7 |
1999 | 2 | 1 | 3 |
2000 | 4 | 1 | 5 |
2001 | 6 | 2 | 8 |
2002 | 7 | 2 | 9 |
2003 | 14 | 9 | 23 |
2004 | 11 | 6 | 17 |
2005 | 11 | 7 | 18 |
2006 | 19 | 9 | 28 |
2007 | 18 | 5 | 23 |
2008 | 15 | 9 | 24 |
2009 | 21 | 9 | 30 |
2010 | 19 | 6 | 25 |
2011 | 31 | 5 | 36 |
2012 | 15 | 5 | 20 |
2013 | 10 | 1 | 11 |
2014 | 20 | 6 | 26 |
2015 | 6 | 3 | 9 |
2016 | 9 | 8 | 17 |
2017 | 12 | 6 | 18 |
2018 | 11 | 5 | 16 |
2019 | 14 | 4 | 18 |
2020 | 11 | 5 | 16 |
2021 | 12 | 0 | 12 |
2022 | 7 | 0 | 7 |
2023 | 7 | 0 | 7 |
2024 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Cancer Vaccines" by people in Profiles.
-
Multipeptide vaccines for melanoma in the adjuvant setting: long-term survival outcomes and post-hoc analysis of a randomized phase II trial. Nat Commun. 2024 Mar 22; 15(1):2570.
-
Identification of a Self-Assembling Small-Molecule Cancer Vaccine Adjuvant with an Improved Toxicity Profile. J Med Chem. 2023 09 28; 66(18):13266-13279.
-
Chimeric RNAs reveal putative neoantigen peptides for developing tumor vaccines for breast cancer. Front Immunol. 2023; 14:1188831.
-
Worth a Pound of Cure? Emerging Strategies and Challenges in Cancer Immunoprevention. Cancer Prev Res (Phila). 2023 09 01; 16(9):483-495.
-
Novel Immunotherapeutics: Perspectives on Checkpoints, Bispecifics, and Vaccines in Development. Am Soc Clin Oncol Educ Book. 2023 Jun; 43:e391278.
-
Phase II Trial of Nelipepimut-S Peptide Vaccine in Women with Ductal Carcinoma In Situ. Cancer Prev Res (Phila). 2023 06 01; 16(6):333-341.
-
Naproxen chemoprevention induces proliferation of cytotoxic lymphocytes in Lynch Syndrome colorectal mucosa. Front Immunol. 2023; 14:1162669.
-
CD73-Dependent Adenosine Signaling through Adora2b Drives Immunosuppression in Ductal Pancreatic Cancer. Cancer Res. 2023 04 04; 83(7):1111-1127.
-
Image-guided intratumoral immunotherapy: Developing a clinically practical technology. Adv Drug Deliv Rev. 2022 10; 189:114505.
-
Neoantigen-based cancer vaccination using chimeric RNA-loaded dendritic cell-derived extracellular vesicles. J Extracell Vesicles. 2022 08; 11(8):e12243.